Is Altamira Therapeutics Ltd (CYTO) Stock a Smart Value Thursday?

A rating of 13 puts Altamira Therapeutics Ltd (CYTO) near the top of the Healthcare sector according to InvestorsObserver. Altamira Therapeutics Ltd's score of 13 means that it ranks higher than 13% of stocks in the sector. In addition, its overall score of 25 ranks it higher than 25% of all stocks.

CYTO has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on CYTO!

See Full CYTO Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 25 would rank higher than 25 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Altamira Therapeutics Ltd Stock Today?

Altamira Therapeutics Ltd (CYTO) stock is trading at $2.17 as of 2:56 PM on Thursday, Mar 28, a decline of -$0.18, or -7.66% from the previous closing price of $2.35. The stock has traded between $2.17 and $2.49 so far today. Volume today is below average. So far 226,995 shares have traded compared to average volume of 2,337,191 shares. Click Here to get the full Stock Report for Altamira Therapeutics Ltd stock.